Bibliography
Found 105 results
Filters: Keyword is HIV-1 [Clear All Filters]
Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J Neurochem. 2007 ;103(2):439-55.
Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett. 2014 ;558:97-102.
. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 ;23(2):290-303.
. . . Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.
. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. J Infect Dis. 2023 ;227(Suppl 1):S3-S15.
. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019 ;142(3):502-511.
. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest. 2023 ;133(12).
Brain-specific HIV Nef identified in multiple patients with neurological disease. J Neurovirol. 2018 ;24(1):1-15.
. A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease. J Int Assoc Provid AIDS Care. 2014 ;13(3):196-9.
. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathology (Zurich, Switzerland) [Internet]. 2006 ;16(4):256-65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107594
. Cellular immunology in HIV-1 positive African American women using alcohol and cocaine. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2006 ;11:2434-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16720325
. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Journal of NeuroVirology [Internet]. 2006 ;12(3):178-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877299
Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. Journal of Proteome Research [Internet]. 2007 ;6:4189-99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17929958
. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8(+) T cells with JCV-infected glial cells. Journal of Neurovirology [Internet]. 2006 ;12(2):116-28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798673
. Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. Journal of Neurovirology [Internet]. 2008 ;14:17-27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18300072
. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.
. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. Journal of Virology [Internet]. 2007 ;81:6643-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17428864
. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol. 2011 ;85(5):2397-405.
. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.
Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Frontiers in Bioscience: A Journal and Virtual Library [Internet]. 2007 ;12:1488-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17127396
. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745
. Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. AIDS Patient Care and STDs [Internet]. 2006 ;20(8):576-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16893327
. Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. J Neuroimmune Pharmacol. 2016 ;11(3):495-510.
.